News - Page 281 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article Champignon Brands ($SHRM) Trading Halt

Champignon Brands ($SHRM) Trading Halt

Post published:May 11, 2020
Post category:Press Release

Read more about the article NewLeaf Brands Appoints Former Manager of Ebbu & Co-founder of Mydecine, Damon Michaels, as COO

NewLeaf Brands Appoints Former Manager of Ebbu & Co-founder of Mydecine, Damon Michaels, as COO

Post published:May 11, 2020
Post category:Press Release

Read more about the article Champignon Appoints Dr. Roger McIntyre as Chief Executive Officer

Champignon Appoints Dr. Roger McIntyre as Chief Executive Officer

Post published:May 11, 2020
Post category:Press Release

Read more about the article Private Financing: Entheon Biomedical

Private Financing: Entheon Biomedical

Post published:May 7, 2020
Post category:Private Financing

Read more about the article Revive Therapeutics Provides an Update on its Psilocybin-Based Pharmaceutical Program

Revive Therapeutics Provides an Update on its Psilocybin-Based Pharmaceutical Program

Post published:April 29, 2020
Post category:Press Release

Read more about the article Interview with CaaMTech

Interview with CaaMTech

Post published:April 28, 2020
Post category:Interview

Read more about the article Interview with Ronan Levy, Founder of Field Trip Health

Interview with Ronan Levy, Founder of Field Trip Health

Post published:April 16, 2020
Post category:Interview

Read more about the article Psychedelic Investments Week in Review (28 March 2020)

Psychedelic Investments Week in Review (28 March 2020)

Post published:March 28, 2020
Post category:News

Read more about the article Champignon Expands Preclinical Pipeline with Measured Psilocybin Dosages Studies at University of Miami

Champignon Expands Preclinical Pipeline with Measured Psilocybin Dosages Studies at University of Miami

Post published:March 27, 2020
Post category:Press Release

Read more about the article Cannabis Company Hollister Biosciences Signs Letter of Intent to Acquire Mushroom-based Health Company Alphamind Brands

Cannabis Company Hollister Biosciences Signs Letter of Intent to Acquire Mushroom-based Health Company Alphamind Brands

Post published:March 13, 2020
Post category:News

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.